Genes & Genomics

, Volume 38, Issue 2, pp 217–223 | Cite as

miRNA-105 and -128 function as rheostats modulating MMP-2 activities by downregulation of TIMP-2 and upregulation of MT1-MMP

  • Jin Hee Kim
  • Li-Hua Li
  • Hua Cai
  • Vu H. Nguyen
  • Jung-Joon Min
  • Boo Ahn ShinEmail author
  • Seok-Yong ChoiEmail author
  • Yang Seok KohEmail author
Research Article


Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that remodel and degrade the extracellular matrix. Of various MMPs, MMP-2 plays an important role in tumor metastasis. Recently, microRNAs with pro- or anti-metastatic effects were collectively referred to as metastamiRs. We screened 215 human miRNA mimics for modulators of MMP-2 activities in HT-1080 cells, and found that miR-105 and miR-128 promote MMP-2 activities. Bioinformatics analysis predicted that miR-105 and miR-128 both bind to the 3′ untranslated region (UTR) of TIMP-2, an inhibitor of MMP-2 activities. This prediction was verified by reduced luciferase activity in HT-1080 cells co-transfected with miR-105 or miR-128 mimics and plasmids encoding luciferase fused to 3′ UTR of TIMP2. In addition, Western blotting showed that transfection of HT-1080 cells with miR-105 or miR-128 suppressed TIMP-2 levels and enhanced levels of MT1-MMP, an activator of MMP-2 activities. The mechanism by which miR-128 upregulates MT1-MMP was determined to be downregulation of PRKD1, an inhibitor of MT1-MMP, at least in part. Cell invasion assays using Matrigel demonstrated that HT-1080 cells transfected with miR-105 or miR-128 are more invasive as compared to control cells. Taken together, these findings show that miR-105 and miR-128 are metastamir promoting MMP-2 activities via simultaneously downregulating TIMP-2 and upregulating MT1-MMP, and may provide a platform for the development of therapeutics against metastasis.


microRNA Metastasis Matrix metalloproteinase MMP-2 MT1-MMP TIMP-2 Protein kinase D 



This work was supported by Chonnam National University Hospital Biomedical Research Institute (CRI 11002-1 and HCRI 14023-1) and Chonnam National University (2011-2495). We thank Gary Jenkins for English editing and Eun Young Choi for encouragement.

Compliance with ethical standards

Conflict of interest

The authors have declared that they have no conflicts of interests.


  1. Akhtar N, Rasheed Z, Ramamurthy S, Anbazhagan AN, Voss FR, Haqqi TM (2010) miRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheumatol 62:1361–1371CrossRefGoogle Scholar
  2. Bartel DP (2009) miRNAs: target recognition and regulatory functions. Cell 136:215–233PubMedCentralCrossRefPubMedGoogle Scholar
  3. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, Stathopoulou P, Knudsen TB, Kinane DF (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J Biol Chem 284:23107–23115PubMedCentralCrossRefPubMedGoogle Scholar
  4. Benet M, Dulman RY, Suzme R, de Miera EV, Vega ME, Nguyen T, Zavadil J, Pellicer A (2012) Wild type N-ras displays anti-malignant properties, in part by downregulating decorin. J Cell Physiol 227:2341–2351PubMedCentralCrossRefPubMedGoogle Scholar
  5. Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H (2000) Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem 275:26416–26422CrossRefPubMedGoogle Scholar
  6. Chernov AV, Sounni NE, Remacle AG, Strongin AY (2009) Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J Biol Chem 284:12727–12734PubMedCentralCrossRefPubMedGoogle Scholar
  7. Eiseler T, Doppler H, Yan IK, Goodison S, Storz P (2009) Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res 11:R13PubMedCentralCrossRefPubMedGoogle Scholar
  8. Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, Zhang JP, Guan XY, Zhuang SM (2011) miRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54:1729–1740CrossRefPubMedGoogle Scholar
  9. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM (2008) miRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28:5369–5380PubMedCentralCrossRefPubMedGoogle Scholar
  10. Gingras D, Beliveau R (2010) Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim Biophys Acta 1803:142–150CrossRefPubMedGoogle Scholar
  11. Honeywell DR, Cabrita MA, Zhao H, Dimitroulakos J, Addison CL (2013) miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS ONE 8:e70515PubMedCentralCrossRefPubMedGoogle Scholar
  12. Hsiao CC, Wang WC, Kuo WL, Chen HY, Chen TC, Hamann J, Lin HH (2014) CD97 inhibits cell migration in human fibrosarcoma cells by modulating TIMP-2/MT1- MMP/MMP-2 activity-role of GPS autoproteolysis and functional cooperation between the N- and C-terminal fragments. FEBS J 281:4878–4891CrossRefPubMedGoogle Scholar
  13. Hurst DR, Edmonds MD, Welch DR (2009) Metastamir: the field of metastasis-regulatory miRNA is spreading. Cancer Res 69:7495–7498PubMedCentralCrossRefPubMedGoogle Scholar
  14. Hurteau GJ, Spivack SD, Brock GJ (2006) Potential miRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle 5:1951–1956CrossRefPubMedGoogle Scholar
  15. Iorio MV, Croce CM (2012) miRNA involvement in human cancer. Carcinogenesis 33:1126–1133PubMedCentralCrossRefPubMedGoogle Scholar
  16. Jonas S, Izaurralde E (2015) Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16:421–433CrossRefPubMedGoogle Scholar
  17. Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67PubMedCentralCrossRefPubMedGoogle Scholar
  18. Kessenbrock K, Wang CY, Werb Z (2015) Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol 44–46:184–190Google Scholar
  19. Kim YK (2015) Extracellular microRNAs as biomarkers in human disease. Chonnam Med J 51:51–57PubMedCentralCrossRefPubMedGoogle Scholar
  20. Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA, Choi SY (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS ONE 6:e18556PubMedCentralCrossRefPubMedGoogle Scholar
  21. Kim JH, Kim BK, Kim DW, Shin HY, Yu SB, Kim DS, Ryu SJ, Kim KH, Jang HK, Kim JD (2014) Effect of propofol on miRNA expression profile in adipocyte-derived adult stem cells. Chonnam Med J 50:86–90PubMedCentralCrossRefPubMedGoogle Scholar
  22. Koh YS, Kim JH, Cai H, Li LH, Kim HS, Kim K, Kim N, Shin BA, Lee T, Choi SY et al (2013) Dysregulated miRNAs in non-cirrhotic hepatocellular carcinoma. Genes Genom 37:759–765CrossRefGoogle Scholar
  23. Koo BH, Kim YH, Han JH, Kim DS (2012) Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation. J Biol Chem 287:22643–22653PubMedCentralCrossRefPubMedGoogle Scholar
  24. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are miRNA targets. Cell 120:15–20CrossRefPubMedGoogle Scholar
  25. Li LH, Baek IK, Kim JH, Kang KH, Koh YS, Jung YD, Cho CK, Choi SY, Shin BA (2009) Methanol extract of Elaeagnus glabra, a Korean medicinal plant, inhibits HT1080 tumor cell invasion. Oncol Rep 21:559–563PubMedGoogle Scholar
  26. Liu P, Wilson MJ (2012) miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-kappaB factor in human fibrosarcoma cells. J Cell Physiol 227:867–876PubMedCentralCrossRefPubMedGoogle Scholar
  27. Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS (2004) Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Lab Investig 84:8–20CrossRefPubMedGoogle Scholar
  28. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by miRNA-10b in breast cancer. Nature 449:682–688CrossRefPubMedGoogle Scholar
  29. Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458CrossRefPubMedGoogle Scholar
  30. Papagiannakopoulos T, Friedmann-Morvinski D, Neveu P, Dugas JC, Gill RM, Huillard E, Liu C, Zong H, Rowitch DH, Barres BA et al (2012) Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 31:1884–1895PubMedCentralCrossRefPubMedGoogle Scholar
  31. Qian P, Zuo Z, Wu Z, Meng X, Li G, Zhang W, Tan S, Pandey V, Yao Y, Wang P et al (2011) Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res 71:6463–6474CrossRefPubMedGoogle Scholar
  32. Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Bluthgen N, Marks DS, van Oudenaarden A (2015) Gene expression. miRNA control of protein expression noise. Science 348:128–132CrossRefPubMedGoogle Scholar
  33. Shen L, Chen XD, Zhang YH (2014) miRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol 35:2069–2074CrossRefPubMedGoogle Scholar
  34. Strongin AY, Marmer BL, Grant GA, Goldberg GI (1993) Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268:14033–14039PubMedGoogle Scholar
  35. Talmadge JE, Fidler IJ (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70:5649–5669PubMedCentralCrossRefPubMedGoogle Scholar
  36. Tan CL, Plotkin JL, Veno MT, von Schimmelmann M, Feinberg P, Mann S, Handler A, Kjems J, Surmeier DJ, O’Carroll D et al (2013) miRNA-128 governs neuronal excitability and motor behavior in mice. Science 342:1254–1258PubMedCentralCrossRefPubMedGoogle Scholar
  37. Wang Z, Juttermann R, Soloway PD (2000) TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275:26411–26415PubMedCentralCrossRefPubMedGoogle Scholar
  38. Wang Y, Lin T, Zhang W, Jiang Y, Jin H, He H, Yang VC, Chen Y, Huang Y (2015) A prodrug-type, mmp-2-targeting nanoprobe for tumor detection and imaging. Theranostics 5:787–795PubMedCentralCrossRefPubMedGoogle Scholar
  39. Weng C, Dong H, Chen G, Zhai Y, Bai R, Hu H, Lu L, Xu Z (2012) miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Lett 323:171–179CrossRefPubMedGoogle Scholar
  40. Yang CH, Yue J, Pfeffer SR, Handorf CR, Pfeffer LM (2011) miRNA-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 286:39172–39178PubMedCentralCrossRefPubMedGoogle Scholar
  41. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O’Connor ST, Chin AR et al (2014) Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25:501–515PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© The Genetics Society of Korea and Springer-Science and Media 2015

Authors and Affiliations

  1. 1.Department of MicrobiologyChonnam National University Medical SchoolGwangjuRepublic of Korea
  2. 2.Department of Pathogen BiologyHainan Medical UniversityHaikouPeople’s Republic of China
  3. 3.Department of Biomedical SciencesChonnam National University Medical SchoolGwangjuRepublic of Korea
  4. 4.Department of Nuclear MedicineChonnam National University Medical SchoolGwangjuRepublic of Korea
  5. 5.Department of SurgeryChonnam National University Medical SchoolGwangjuRepublic of Korea

Personalised recommendations